Jefferies Financial Group Inc. Has $8.07 Million Stock Holdings in GE HealthCare Technologies Inc. $GEHC

Jefferies Financial Group Inc. raised its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 27.8% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 107,396 shares of the company’s stock after acquiring an additional 23,362 shares during the period. Jefferies Financial Group Inc.’s holdings in GE HealthCare Technologies were worth $8,065,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors also recently modified their holdings of the company. Allianz SE boosted its position in shares of GE HealthCare Technologies by 165.2% during the second quarter. Allianz SE now owns 350 shares of the company’s stock worth $26,000 after buying an additional 218 shares during the period. E Fund Management Hong Kong Co. Ltd. raised its position in GE HealthCare Technologies by 130.7% in the 3rd quarter. E Fund Management Hong Kong Co. Ltd. now owns 346 shares of the company’s stock valued at $26,000 after buying an additional 196 shares during the last quarter. Godsey & Gibb Inc. bought a new stake in GE HealthCare Technologies in the 3rd quarter valued at approximately $26,000. Oakworth Capital Inc. lifted its stake in GE HealthCare Technologies by 1,876.2% in the 3rd quarter. Oakworth Capital Inc. now owns 415 shares of the company’s stock valued at $31,000 after acquiring an additional 394 shares in the last quarter. Finally, Piscataqua Savings Bank boosted its position in GE HealthCare Technologies by 173.4% during the 3rd quarter. Piscataqua Savings Bank now owns 473 shares of the company’s stock worth $36,000 after acquiring an additional 300 shares during the last quarter. 82.06% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on GEHC. Wall Street Zen raised shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating in a research report on Saturday. Piper Sandler boosted their price target on shares of GE HealthCare Technologies from $91.00 to $94.00 and gave the stock an “overweight” rating in a research report on Friday, January 30th. Morgan Stanley increased their price objective on shares of GE HealthCare Technologies from $80.00 to $85.00 and gave the stock an “equal weight” rating in a research note on Wednesday, February 4th. The Goldman Sachs Group restated a “buy” rating and issued a $98.00 price objective on shares of GE HealthCare Technologies in a report on Friday, January 9th. Finally, Wells Fargo & Company upped their target price on GE HealthCare Technologies from $95.00 to $97.00 and gave the stock an “overweight” rating in a report on Thursday, February 5th. Seven research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, GE HealthCare Technologies presently has a consensus rating of “Hold” and an average target price of $92.50.

GE HealthCare Technologies Price Performance

GE HealthCare Technologies stock opened at $75.63 on Tuesday. The company has a market capitalization of $34.47 billion, a price-to-earnings ratio of 16.59, a PEG ratio of 1.63 and a beta of 1.03. The company has a current ratio of 1.37, a quick ratio of 1.13 and a debt-to-equity ratio of 0.91. GE HealthCare Technologies Inc. has a 12 month low of $57.65 and a 12 month high of $89.77. The stock’s 50 day moving average is $81.66 and its 200-day moving average is $78.62.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings results on Wednesday, February 4th. The company reported $1.44 EPS for the quarter, beating the consensus estimate of $1.40 by $0.04. GE HealthCare Technologies had a net margin of 10.11% and a return on equity of 21.35%. The business had revenue of $5.70 billion for the quarter, compared to the consensus estimate of $5.60 billion. During the same period in the prior year, the company posted $1.45 earnings per share. GE HealthCare Technologies’s revenue was up 7.1% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. Equities research analysts expect that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, May 15th. Investors of record on Friday, April 3rd will be issued a dividend of $0.035 per share. The ex-dividend date of this dividend is Thursday, April 2nd. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. GE HealthCare Technologies’s payout ratio is 3.07%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.